Mitesco (MITI) Net Income towards Common Stockholders (2011 - 2026)
Mitesco's (MITI) quarterly Net Income towards Common Stockholders came in at -$803603.0 in Q1 2026, down 123.38% year-on-year from $3.4 million in Q1 2025, and down 357.21% on a QoQ basis from $312429.0 in Q4 2025.
Mitesco (MITI) Net Income towards Common Stockholders (2011 - 2026) Analysis & Trends
Mitesco (MITI) has 16 years of Net Income towards Common Stockholders data on file, last reported at -$803603.0 in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 123.38% year-over-year to -$803603.0 in Q1 2026; TTM through Mar 2026 was -$3.8 million, a 421.02% decrease from a year earlier, with the FY2025 full-year figure at $429413.0, up 115.11% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$803603.0, down from $312429.0 in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for MITI reached as high as $3.4 million in Q1 2025 and fell as low as -$16.8 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged -$2.7 million across 5 years, with a median of -$2.6 million in 2023.
- Across the five-year window, Net Income towards Common Stockholders plunged 578.64% in 2024 and jumped 7488.95% in 2025, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$16.8 million in 2022, then jumped by 104.38% to $738426.0 in 2023, then plunged by 578.64% to -$3.5 million in 2024, then surged by 108.84% to $312429.0 in 2025, then plunged by 357.21% to -$803603.0 in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$803603.0 in Q1 2026, $312429.0 in Q4 2025, and -$3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.76 Bn | 24.44 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 14.62 Bn | 13.72 Bn | 482.22 Mn | 148.77 Mn |
| 3 | Healthequity | 8.33 Bn | 8.06 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.94 Bn | 5.63 Bn | 154.23 Mn | 34.01 Mn |
| 5 | 10x Genomics | 5.81 Bn | 5.27 Bn | 106.18 Mn | -13.47 Mn |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 43.28 Mn |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | 19.11 Mn |
| 9 | Privia Health | 3.17 Bn | 2.75 Bn | - | 3.71 Mn |
| 10 | Mitesco | 861,250.76 | 859,717.76 | - | -803,603.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -803,603.00 |
| Dec 31, 2025 | 312,429.00 |
| Sep 30, 2025 | -3.22 Mn |
| Jun 30, 2025 | -99,698.00 |
| Mar 31, 2025 | 3.44 Mn |
| Dec 31, 2024 | -3.53 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | -769,335.00 |
| Mar 31, 2024 | -46,524.00 |
| Dec 31, 2023 | 738,426.00 |
| Sep 30, 2023 | -2.56 Mn |
| Jun 30, 2023 | -8.01 Mn |
| Mar 31, 2023 | -5.69 Mn |
| Dec 31, 2022 | -16.85 Mn |
| Sep 30, 2022 | -2.71 Mn |
| Jun 30, 2022 | -3.89 Mn |
| Mar 31, 2022 | -3.72 Mn |
| Dec 31, 2021 | -5.14 Mn |
| Sep 30, 2021 | -1.81 Mn |
| Jun 30, 2021 | -1.52 Mn |